NCT06400472 2026-01-14A Study of LY4170156 in Participants With Selected Advanced Solid TumorsEli Lilly and CompanyPhase 1 Recruiting495 enrolled
NCT06297811 2024-03-07Myeloprotection With Trilaciclib in Pan-cancer PopulationSun Yat-sen UniversityPhase 2 Not yet recruiting132 enrolled
NCT02476955 2020-09-30Open-label Phase 1b Study of ARQ 092 in Combination With AnastrozoleArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)Phase 1 Terminated41 enrolled